palbociclib

CDK 4/6 inhibitors

Scoring is done by our AI based assistant on the data from the FDA and other sources

4.8

10

Effectiveness

Safety

Addiction

Ease of Use

Contraindications

6.7

Kisqali (600 mg daily-dose)

6.1

Ribociclib

5.2

Kisqali (400 mg daily-dose)

5.2

Verzenio

5.2

Ibrance

5.0

Kisqali

5.0

Abemaciclib

4.8

Kisqali (200 mg daily-dose)

4.8

Palbociclib